Case Study: Discussing a Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Safety
Time: 1:45 pm
day: Day Two
Details:
- Displaying novel approaches and innovative technologies to showcase future horizons for formula applications
- Communicating the rationale behind using non-standard and non-approved bioactive approaches to encourage innovation
- Demonstrating proof of concept for humanization of formula ingredients to engage support for experimental trials and regulatory plans
